Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Increasing Point-of-Care Testing Workload Addressed with New Integrated Systems Solution

By LabMedica International staff writers
Posted on 17 Mar 2015
Challenges faced by clinical laboratory point-of-care (POC) coordinators can now be more efficiently tackled with an innovative approach developed as a new component of an informatics solution for managing in vitro diagnostics (IVD) analyzers and operators.

Siemens Healthcare Diagnostics, of Siemens AG (Berlin and Munich, Germany), now offers its new Ecosystem solution, an integrated component of its RAPIDComm Data Management System, an informatics solution that centrally manages Siemens IVD analyzers and operators. More...


Ecosystem, which encompasses eight core components, includes device management, operator management, quality control, compliance reporting, competency management, inventory management, remote monitoring, and mobile access.

“Siemens Healthcare Diagnostics has been carefully analyzing the POC market and is ready to provide a holistic approach to testing,” said Afia Boamah, product manager of Blood Gas, Stratus CS & POC IT S at Siemens Healthcare Diagnostics, “POC testing continues to grow at a rapid pace and there is a strong need to provide fast and reliable results.” “Although solutions for each of the 8 core components do exist individually, efficiently managing all aspects of a POC testing program requires close collaboration among hospitals, device manufacturers, and IT vendors. The Siemens POC Ecosystem helps to address this challenge by implementing an integrated solution which improves the efficiency and effectiveness of POC programs,” added A. Boamah.

Ecosystem takes the core needs of a POC program into consideration with a focus on helping POC coordinators improve control, effectiveness, and transparency. It manages secure access to POC devices, oversees quality control, manages staff training, and identifies and resolves issues - from any location via the remote access facility. This helps ensure manageability of instruments and consumables for potentially hundreds of testing devices. External compliance requirements are also met, while reducing costs.

“We are working hand-in-hand with healthcare providers to adapt to clinical environments making use of handheld IT devices such as tablets and smart phones. The Ecosystem solution allows POC data management from anywhere within a hospital using these devices, which improves the ability of POC coordinators to quickly and efficiently resolve issues. This has been highlighted by customers as a critical requirement in a fast-paced laboratory environment,” said A. Boamah.

Related Links:

Siemens 
Siemens Healthcare 



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.